![Show Menu](styles/mobile-menu.png)
![Page Background](./../common/page-substrates/page0682.jpg)
Reporting dose
•
Lax et al. 1993:
Ø
Normalizing to the 65%-isodose leads to a 50% increase of dose in
the target center without substantial increase of dose outside the
PTV in comparison to dose loads for a homogenous dose
distribution
•
This is all very nice, but how do we know what exactly was
reported in literature? To quote ICRU 91:
Ø
“Despite the long clinical history of SRT for intracranial lesions, at the
time of writing of this report, around
14 000 clinical manuscripts
on
stereotactic radiotherapy have been reported in PubMed with Phase
III studies only in brain metastases.
Prescribing, reporting, and
recording are performed in different ways at different
institutions which emphasizes the need for the present Report
to standardize the process
.”
SBRT 2017 - D. Verellen